Gad Thomas
SEC insider (Form 3/4/5 filer). CIK 0001753224. CHIEF BUSINESS OFFICER at Y-mAbs Therapeutics, Inc. (YMAB). 10 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2025. Located in NEW YORK, NY.
Companies Gad Thomas has filed insider reports for
- Y-mAbs Therapeutics, Inc. (YMAB): Director, Officer, CHIEF BUSINESS OFFICER
Gad Thomas
CIK: 0001753224
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Y-mAbs Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Sep 16, 2025YMAB
Y-mAbs Therapeutics, Inc.
Tender OfferDirect245.5K shares at avg. $8.60$2.1M - Sep 16, 2025YMAB
Y-mAbs Therapeutics, Inc.
DispositionDirect60.2K shares- - Sep 16, 2025YMAB
Y-mAbs Therapeutics, Inc.
Tender OfferIndirect67.7K shares at avg. $8.60$582K - Sep 16, 2025YMAB
Y-mAbs Therapeutics, Inc.
Tender OfferIndirect60K shares at avg. $8.60$516K - Jun 3, 2025YMAB
Y-mAbs Therapeutics, Inc.
ExerciseDirect103K shares at avg. $2.00$206K - Mar 7, 2025YMAB
Y-mAbs Therapeutics, Inc.
SaleDirect10.8K shares at avg. $5.23$57K - Jan 17, 2025YMAB
Y-mAbs Therapeutics, Inc.
AwardDirect32K shares- - Sep 19, 2024YMAB
Y-mAbs Therapeutics, Inc.
ExerciseDirect22.8K shares at avg. $4.38$100K - Sep 16, 2024YMAB
Y-mAbs Therapeutics, Inc.
SaleIndirect30K shares at avg. $12.97$389K - Sep 13, 2024YMAB
Y-mAbs Therapeutics, Inc.
SaleIndirect65K shares at avg. $13.47$876K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | Tender Offer | 245,486 | $8.60 | $2,111,180 | Direct |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | Disposition | 60,235 | - | - | Direct |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | Tender Offer | 67,681 | $8.60 | $582,057 | Indirect |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | Tender Offer | 60,000 | $8.60 | $516,000 | Indirect |
| Jun 3, 2025 | YMAB Y-mAbs Therapeutics, Inc. | Exercise | 103,000 | $2.00 | $206,000 | Direct |
| Mar 7, 2025 | YMAB Y-mAbs Therapeutics, Inc. | Sale | 10,810 | $5.23 | $56,536 | Direct |
| Jan 17, 2025 | YMAB Y-mAbs Therapeutics, Inc. | Award | 32,000 | - | $0 | Direct |
| Sep 19, 2024 | YMAB Y-mAbs Therapeutics, Inc. | Exercise | 22,831 | $4.38 | $100,000 | Direct |
| Sep 16, 2024 | YMAB Y-mAbs Therapeutics, Inc. | Sale | 30,000 | $12.97 | $389,100 | Indirect |
| Sep 13, 2024 | YMAB Y-mAbs Therapeutics, Inc. | Sale | 65,000 | $13.47 | $875,550 | Indirect |
1-10 of 10 transactions